×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ZBIO – zenas biopharma, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ZBIO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/23
04:14 pm
zbio
Zenas BioPharma (NASDAQ:ZBIO) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Zenas BioPharma (NASDAQ:ZBIO) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
12/22
12:23 pm
zbio
Zenas BioPharma Seen Attractive Ahead of IgG4-RD Phase 3 Update, Wedbush Says [Yahoo! Finance]
Medium
Report
Zenas BioPharma Seen Attractive Ahead of IgG4-RD Phase 3 Update, Wedbush Says [Yahoo! Finance]
12/22
08:42 am
zbio
Zenas BioPharma (NASDAQ:ZBIO) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $45.00 price target on the stock.
High
Report
Zenas BioPharma (NASDAQ:ZBIO) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $45.00 price target on the stock.
12/19
04:23 pm
zbio
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
High
Report
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
12/19
04:15 pm
zbio
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
High
Report
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/16
04:43 pm
zbio
Zenas BioPharma (NASDAQ:ZBIO) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Zenas BioPharma (NASDAQ:ZBIO) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
12/16
08:43 am
zbio
Zenas BioPharma (NASDAQ:ZBIO) had its "buy" rating reaffirmed by analysts at HC Wainwright.
High
Report
Zenas BioPharma (NASDAQ:ZBIO) had its "buy" rating reaffirmed by analysts at HC Wainwright.
12/15
08:17 am
zbio
Zenas BioPharma's Partner, InnoCare Pharma, Announces Achievement of Primary Endpoint in Phase 2b Study of Orelabrutinib, a BTK Inhibitor, for Systemic Lupus Erythematosus [Yahoo! Finance]
High
Report
Zenas BioPharma's Partner, InnoCare Pharma, Announces Achievement of Primary Endpoint in Phase 2b Study of Orelabrutinib, a BTK Inhibitor, for Systemic Lupus Erythematosus [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/19
05:01 pm
zbio
Form S-8 Zenas BioPharma, Inc.
High
Report
Form S-8 Zenas BioPharma, Inc.
12/15
04:31 pm
zbio
Form 8-K Zenas BioPharma, Inc. For: Dec 10
High
Report
Form 8-K Zenas BioPharma, Inc. For: Dec 10
11/14
06:29 pm
zbio
Form SCHEDULE 13G/A Zenas BioPharma, Inc. Filed by: Novo Holdings A/S
Low
Report
Form SCHEDULE 13G/A Zenas BioPharma, Inc. Filed by: Novo Holdings A/S
11/12
07:20 am
zbio
Form 10-Q Zenas BioPharma, Inc. For: Sep 30
Low
Report
Form 10-Q Zenas BioPharma, Inc. For: Sep 30
11/12
07:13 am
zbio
Form 8-K Zenas BioPharma, Inc. For: Nov 12
Low
Report
Form 8-K Zenas BioPharma, Inc. For: Nov 12
10/27
07:19 am
zbio
Form 8-K Zenas BioPharma, Inc. For: Oct 27
High
Report
Form 8-K Zenas BioPharma, Inc. For: Oct 27
10/21
04:46 pm
zbio
Form S-3ASR Zenas BioPharma, Inc.
Medium
Report
Form S-3ASR Zenas BioPharma, Inc.
10/15
06:13 am
zbio
Form SCHEDULE 13G Zenas BioPharma, Inc. Filed by: InnoCare Pharma Inc.
Low
Report
Form SCHEDULE 13G Zenas BioPharma, Inc. Filed by: InnoCare Pharma Inc.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: